Form 4: Maravai LifeSciences Executive Sells Shares to Cover Tax Obligations

Andrew Burch, a former executive at Maravai LifeSciences, sold 54,412 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Andrew Burch, a former President of Nucleic Acid Production at Maravai LifeSciences, sold 54,412 shares of Class A Common Stock on January 15, 2025.
• The sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock unit awards.
• Following the transaction, Burch directly owns 369,183 shares of Maravai LifeSciences Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The number of shares sold and the price are specific to the individual's compensation package and the company's stock performance.
• Similar transactions are regularly reported by executives at comparable companies in the biotechnology and life sciences sectors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale by an executive to cover tax obligations.

Key Dates

Keywords

Maravai LifeSciences, MRVI, insider trading, stock sale, Form 4, executive, tax obligations, restricted stock units, share sale